摘要
蛇毒是生物活性分子的天然来源,其能够选择性地且特异地在不同的细胞靶上起作用,调节生理功能。因此,这些主要由蛋白质和肽组成的混合物提供了充足和具有挑战性的机会,以及多样化的分子结构来设计和开发具有科学和治疗兴趣的工具和代理。在这些组分中,肽和小蛋白质在许多生理过程中起着不同的作用,发挥广泛的药理活性,例如抗微生物剂,抗高血压药,止痛剂,抗肿瘤剂,止痛剂等。制药和化妆品行业已经认识到这些特权框架的巨大潜力,并相信它们是当代药物有前途的替代品。许多来自蛇毒的天然或合成肽已经发现用于治疗疼痛,高血压,心血管疾病和老化皮肤的临床前或临床应用。一个众所周知的例子是卡托普利,其天然肽前体从Bothrops jararaca蛇毒中分离出来,它是抑制血管紧张素转换酶的基于肽的药物,产生抗高血压作用。本综述着眼于蛇毒的主要肽(利钠肽,缓激肽增强肽和sarafotoxins)和低质量蛋白质(crotamine,去整合素和三指毒素),以及灵感来源于其的合成肽,描述其生物化学,结构和生理特征,以及作为研究工具和治疗剂的应用。
关键词: 卡罗肽,沙拉毒素,利尿钠肽,缓激肽增强肽,解体蛋白,三指毒素。
Current Medicinal Chemistry
Title:Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents
Volume: 24 Issue: 30
关键词: 卡罗肽,沙拉毒素,利尿钠肽,缓激肽增强肽,解体蛋白,三指毒素。
摘要: Snake venoms are natural sources of biologically active molecules that are able to act selectively and specifically on different cellular targets, modulating physiological functions. Thus, these mixtures, composed mainly of proteins and peptides, provide ample and challenging opportunities and a diversified molecular architecture to design and develop tools and agents of scientific and therapeutic interest. Among these components, peptides and small proteins play diverse roles in numerous physiological processes, exerting a wide range of pharmacological activities, such as antimicrobial, antihypertensive, analgesic, antitumor, analgesic, among others. The pharmaceutical and cosmetic industries have recognized the huge potential of these privileged frameworks and believe them to be a promising alternative to contemporary drugs. A number of natural or synthetic peptides from snake venoms have already found preclinical or clinical applications for the treatment of pain, hypertension, cardiovascular diseases and aging skin. A well-known example is captopril, whose natural peptide precursor was isolated from Bothrops jararaca snake venom, which is a peptide-based drug that inhibits the angiotensin-converting enzyme, producing an anti-hypertensive effect. The present review looks at the main peptides (natriuretic peptides, bradykinin-potentiating peptides and sarafotoxins) and low mass proteins (crotamine, disintegrins and three-Finger toxins) from snake venoms, as well as synthetic peptides inspired by them, describing their biochemical, structural and physiological features, as well as their applications as research tools and therapeutic agents.
Export Options
About this article
Cite this article as:
Snake Venom Peptides and Low Mass Proteins: Molecular Tools and Therapeutic Agents, Current Medicinal Chemistry 2017; 24 (30) . https://dx.doi.org/10.2174/0929867323666161028155611
DOI https://dx.doi.org/10.2174/0929867323666161028155611 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
On the Cellular and Molecular Regulatory Transcriptional Mechanisms and Responsive Putative Pathways to Inflammatory Oxidative Stress Revisited: Current Immunological Breakthroughs and Views at a Glance
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mechanisms Linking Leptin to Arterial and Venous Thrombosis: Potential Pharmacological Targets
Current Pharmaceutical Design Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Association Between Vitamin D Serum Level and Depression
Current Psychopharmacology Insulin Resistance and Hypertension
Current Hypertension Reviews Maternal Nutrient Restriction is not Equivalent to Maternal Biological Stress
Current Drug Targets The Pathophysiology of Sleep Apnoea: What We have Learned from Animal Models of Chronic Intermittent Hypoxia
Current Respiratory Medicine Reviews Editorial [Hot Topic: Perspectives of New Antihypertensive Drugs (Executive Editor: Ji-Guang Wang)]
Current Pharmaceutical Design Evaluating the Risk of Covid-19 Transmission from Conjunctival and Lacrimal Discharge: A Review
Current Biotechnology A Review of the Therapeutic Benefits of Moringa oleifera in Controlling High Blood Pressure (Hypertension)
Current Traditional Medicine Chromogranin A in Tumors: More Than a Marker for Diagnosis and Prognosis
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Current Alzheimer Research Neurovascular Role of Sympathetic Nervous System and Beta-Adrenoceptor Polymorphisms in Obesity and Hypertension
Current Hypertension Reviews Neuroprotective Effects of Estrogens: Cross-Talk Between Estrogen and Intracellular Insulin Signalling
Infectious Disorders - Drug Targets Desensitization Protocol for Rituximab-Induced Serum Sickness
Current Drug Safety Current and Future Drug Treatments for Glioblastomas
Current Medicinal Chemistry Genes, Environment, Intermediate Phenotypes, and the Pathogenesis of Diabetic Nephropathy
Current Pharmacogenomics Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease
Current Molecular Medicine Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Hereditary Haemorrhagic Teleangiectasia: Diagnostic Imaging of Visceral Involvement
Current Pharmaceutical Design